Testing effectiveness (Phase 2)Study completedNCT00736047
What this trial is testing
Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.
Who this might be right for
Smokers
Novartis 200